Why Samsung, Amgen, and Biocon are investing in US pharma facilities
As global trade tensions mount and tariff policy becomes less predictable, international pharmaceutical giants are turning...
Read more
Pharmaceuticals
Tariffs trigger a $270B pharma shift back to US production
In 2025, pharmaceutical manufacturers are facing a fundamental disruption. The US government has proposed new tariffs,...
Read more
US Sees Unprecedented $270 Billion in Manufacturing Plans
Fifteen of the world’s leading pharmaceutical companies are collectively investing more than $270 billion into US-based...
Read more
Amgen Commits $900M to Expand Ohio Biomanufacturing Facility
Amgen has announced a major expansion of its biologic medicines manufacturing facility in New Albany, Ohio....
Read more
Thermo Fisher Invests $2 Billion to Boost US Pharmaceutical Manufacturing
Thermo Fisher Scientific has announced a major investment of $2 billion to expand its manufacturing capabilities...
Read more